By Gianna Ferrarin ( October 8, 2026, 4:56 PM EDT) -- The U.S. Food and Drug Administration anticipates finishing its safety evaluation of mifepristone by March 2027, suggesting a longer horizon for its review of regulations allowing the abortion drug to be dispensed remotely, according to a report filed by the agency in Louisiana federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.